Shepherd Therapeutics transforms the rare cancer landscape

  Shepherd Therapeutics launched in 2016 with a mission to develop breakthrough treatments for rare cancers. Powered by artificial intelligence and machine learning, their drug development pipeline has already yielded seven promising drug assets in preclinical trials. With an innovative drug development pipeline and leadership with decades of experience in biotechnology, Shepherd Therapeutics was featured…

Stasis Labs Improves the Traditional Patient Monitoring Process

  Stasis Labs is a Los Angeles based startup that partners with medical institutions to provide doctors with remote monitoring and predictive artificial intelligence technology that anticipates when an emergency situation will arise before it occurs. I sat down with the company’s founder and president, Michael Maylahn, to discuss Stasis’ innovative approach to healthcare and…